Vor Biopharma Q3 EPS $(0.50) Up From $(61.23) YoY

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.50) per share. This is a 99.18 percent increase over losses of $(61.23) per share from the same period last year.

byBill Haddad

November 10, 2021

1 minute read

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.50) per share. This is a 99.18 percent increase over losses of $(61.23) per share from the same period last year.

Harbor Custom Development Contracts To Sell 144 Entitled Lots In Belfair, WA To Lennar For $10.44M

By Benzinga Newsdesk

Today, 4:13 AM

Harbor Custom Development, Inc. ("Harbor," "Harbor Custom Homes®," or the "Company"), (NASDAQ:HCDI), an innovative and market leading real estate company involved in all aspects of the

HCDI

Here’s How Much The Cheapest Tesla Vehicle Is Now After Price Increases

By Chris Katje

Today, 4:13 AM

The rising costs of nickel and lithium, two key components for electric vehicles, have begun to hit the sector with industry leader Tesla Inc (NASDAQ: TSLA) raising the prices of several vehicle models as a result. Here is a look at what the least expensive Tesla vehicle now costs.

TSLA

News

Polestar Officially Reveals The Polestar 3 Electric Performance SUV; Very High Level Of Standard Equipment Available At Launch; Priced From $83,900

By Benzinga Newsdesk

Today, 4:13 AM

Polestar 3 is the company's first SUV, and its first car planned to be produced on two continents Unique design language inspired by Polestar Precept makes production debut Fully electric 5-seat SUV produces up

PSNY